The Personalized/Precision Medicine Blog
The official blog of the Annual Personalized and Precision Medicine Conference provides readers with information, insight and analysis regarding the field of personalized and precision medicine, genomics, genomic interpretation and the evolution of healthcare in the post-genomic era.
New Policy Primer on Genomic Sequencing: Who Will Pay? Who Should Pay?
- Font size: Larger Smaller
- Hits: 442
- 0 Comments
- Subscribe to this entry
- Bookmark
Genomic sequencing is moving into clinical care, but this technological advance threatens to outpace our ability to use it effectively in clinical practice and to address the associated health policy issues. A key issue is whether payers will cover sequencing and what evidence will be needed to document its value. The TRANSPERS (Ctr for Translational & Policy Research on Personalized Medicine) Center at UC San Francisco has just released a Policy Primer for Genomic Sequencing, the press release for which can be viewed here: http://tinyurl.com/owbzaya.
Dr. Kathryn Phillips, the Center’s Director and Founder, will be discussing UCSF’s work on current coverage policies for gene panels and the factors that determine positive or negative coverage decisions at the 6th Annual Personalized Medicine Conference, taking place in San Francisco on October 29-30, 2014. To request a brochure, visit: http://tinyurl.com/qg5fr4d or visit personalizedmedicinepartnerships.com for more information.